{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:00:41Z","timestamp":1781668841044,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202340054"],"award-info":[{"award-number":["202340054"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-025-02571-7","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:44:14Z","timestamp":1754030654000},"page":"2187-2202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Glucokinase activators contribute to gastrointestinal disease risks through metabolic-immune interplay in the gut-liver axis: insights from a multi-omics study"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-1245","authenticated-orcid":false,"given":"Yunlan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0093-0641","authenticated-orcid":false,"given":"Xing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-9751","authenticated-orcid":false,"given":"Yanhui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"2571_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16087","author":"J Geng","year":"2024","unstructured":"Geng J, Ruan X, Wu X, Chen X, Fu T, Gill D et al (2024) Network Mendelian randomisation analysis Deciphers protein pathways linking type 2 diabetes and Gastrointestinal disease. Diabetes Obes Metab. https:\/\/doi.org\/10.1111\/dom.16087. Epub 2024\/11\/27","journal-title":"Diabetes Obes Metab"},{"key":"2571_CR2","doi-asserted-by":"publisher","first-page":"155999","DOI":"10.1016\/j.metabol.2024.155999","volume":"160","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhou XD, Shapiro MD, Lip GYH, Tilg H, Valenti L et al (2024) Global burden of metabolic diseases, 1990\u20132021. Metabolism 160:155999 Epub 2024\/08\/17. https:\/\/doi.org\/10.1016\/j.metabol.2024.155999","journal-title":"Metabolism"},{"issue":"2","key":"2571_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2337\/dc23-1791","volume":"47","author":"KR Klein","year":"2024","unstructured":"Klein KR, Clemmensen KKB, Fong E, Olsen S, Abrahamsen T, Lingvay I (2024) Occurrence of Gastrointestinal adverse events upon Glp-1 receptor agonist initiation with concomitant Metformin use: A post hoc analysis of leader, step 2, Sustain-6, and pioneer 6. Diabetes Care 47(2):280\u2013284 Epub 2023\/12\/04. https:\/\/doi.org\/10.2337\/dc23-1791","journal-title":"Diabetes Care"},{"key":"2571_CR4","doi-asserted-by":"publisher","unstructured":"Szymczak-Pajor I, Drzewoski J, Wenclewska S, \u015aliwi\u0144ska A (2024) Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis. Pharmaceuticals (Basel) 17(7). Epub 2024\/07\/27. https:\/\/doi.org\/10.3390\/ph17070898","DOI":"10.3390\/ph17070898"},{"issue":"11","key":"2571_CR5","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1007\/s40618-024-02441-z","volume":"47","author":"I Caruso","year":"2024","unstructured":"Caruso I, Di Gioia L, Di Molfetta S, Caporusso M, Cignarelli A, Sorice GP et al (2024) The Real-World safety profile of tirzepatide: pharmacovigilance analysis of the Fda adverse event reporting system (Faers) database. J Endocrinol Invest 47(11):2671\u20132678 Epub 2024\/08\/14. https:\/\/doi.org\/10.1007\/s40618-024-02441-z","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2571_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s11658-024-00640-3","volume":"29","author":"Y Abu Aqel","year":"2024","unstructured":"Abu Aqel Y, Alnesf A, Aigha II, Islam Z, Kolatkar PR, Teo A et al (2024) Glucokinase (Gck) in diabetes: from molecular mechanisms to disease pathogenesis. Cell Mol Biol Lett 29(1):120 Epub 2024\/09\/09. https:\/\/doi.org\/10.1186\/s11658-024-00640-3","journal-title":"Cell Mol Biol Lett"},{"key":"2571_CR7","doi-asserted-by":"publisher","unstructured":"Caturano A, Galiero R, Rocco M, Tagliaferri G, Piacevole A, Nilo D et al (2024) Modern challenges in type 2 diabetes: balancing new medications with multifactorial care. Biomedicines 12(9) Epub 2024\/09\/28 22:43. https:\/\/doi.org\/10.3390\/biomedicines12092039","DOI":"10.3390\/biomedicines12092039"},{"key":"2571_CR8","doi-asserted-by":"publisher","unstructured":"Sj\u00f6holm \u00c5 (2024) Glucokinase Activators and Imeglimin: New Weaponry in the Armamentarium against Type 2 Diabetes. BMJ Open Diabetes Res Care 12(4). Epub 2024\/08\/31. https:\/\/doi.org\/10.1136\/bmjdrc-2024-004291","DOI":"10.1136\/bmjdrc-2024-004291"},{"key":"2571_CR9","doi-asserted-by":"publisher","first-page":"116499","DOI":"10.1016\/j.bcp.2024.116499","volume":"229","author":"BE Ford","year":"2024","unstructured":"Ford BE, Chachra SS, Alshawi A, Oakley F, Fairclough RJ, Smith DM et al (2024) Compromised chronic efficacy of a glucokinase activator Azd1656 in mouse models for common human Gckr variants. Biochem Pharmacol 229:116499 Epub 2024\/08\/23. https:\/\/doi.org\/10.1016\/j.bcp.2024.116499","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2571_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12933-024-02321-z","volume":"23","author":"K Wang","year":"2024","unstructured":"Wang K, Shi M, Luk AOY, Kong APS, Ma RCW, Li C et al (2024) Impaired gk-Gkrp interaction rather than direct gk activation worsens lipid profiles and contributes to Long-Term complications: A Mendelian randomization study. Cardiovasc Diabetol 23(1):228 Epub 2024\/07\/02. https:\/\/doi.org\/10.1186\/s12933-024-02321-z","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2571_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12933-022-01613-6","volume":"21","author":"K Wang","year":"2022","unstructured":"Wang K, Shi M, Huang C, Fan B, Luk AOY, Kong APS et al (2022) Evaluating the impact of glucokinase activation on risk of cardiovascular disease: A Mendelian randomisation analysis. Cardiovasc Diabetol 21(1):192 Epub 2022\/09\/24. https:\/\/doi.org\/10.1186\/s12933-022-01613-6","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2571_CR12","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/dom.14111","volume":"22","author":"BE Ford","year":"2020","unstructured":"Ford BE, Chachra SS, Alshawi A, Brennan A, Harnor S, Cano C et al (2020) Chronic glucokinase activator treatment activates liver carbohydrate response element binding protein and improves hepatocyte Atp homeostasis during substrate challenge. Diabetes Obes Metab 22(11):1985\u20131994 Epub 2020\/06\/11. https:\/\/doi.org\/10.1111\/dom.14111","journal-title":"Diabetes Obes Metab"},{"key":"2571_CR13","doi-asserted-by":"publisher","unstructured":"Haddad D, Dsouza VS, Al-Mulla F, Al Madhoun A (2024) New-Generation Glucokinase Activators: Potential Game-Changers in Type 2 Diabetes Treatment. Int J Mol Sci 25(1). Epub 2024\/01\/11. https:\/\/doi.org\/10.3390\/ijms25010571","DOI":"10.3390\/ijms25010571"},{"issue":"6","key":"2571_CR14","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2337\/db16-1384","volume":"66","author":"CYY Cheung","year":"2017","unstructured":"Cheung CYY, Tang CS, Xu A, Lee CH, Au KW, Xu L et al (2017) An Exome-Chip association analysis in Chinese subjects reveals a functional missense variant of Gckr that regulates Fgf21 levels. Diabetes 66(6):1723\u20131728 Epub 2017\/04\/08. https:\/\/doi.org\/10.2337\/db16-1384","journal-title":"Diabetes"},{"issue":"9","key":"2571_CR15","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman \u00c5K, Kalnapenkis A et al (2023) Genetics of Circulating inflammatory proteins identifies drivers of Immune-Mediated disease risk and therapeutic targets. Nat Immunol 24(9):1540\u20131551 Epub 2023\/08\/11. https:\/\/doi.org\/10.1038\/s41590-023-01588-w","journal-title":"Nat Immunol"},{"issue":"11","key":"2571_CR16","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.2337\/dc22-0323","volume":"45","author":"M Xu","year":"2022","unstructured":"Xu M, Zheng J, Hou T, Lin H, Wang T, Wang S et al (2022) Sglt2 inhibition, choline metabolites, and cardiometabolic diseases: A mediation Mendelian randomization study. Diabetes Care 45(11):2718\u20132728 Epub 2022\/09\/27. https:\/\/doi.org\/10.2337\/dc22-0323","journal-title":"Diabetes Care"},{"issue":"3","key":"2571_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamadermatol.2022.6051","volume":"159","author":"SS Zhao","year":"2023","unstructured":"Zhao SS, Yiu ZZN, Barton A, Bowes J (2023) Association of Lipid-Lowering drugs with risk of psoriasis: A Mendelian randomization study. JAMA Dermatol 159(3):275\u2013280 Epub 2023\/01\/26. https:\/\/doi.org\/10.1001\/jamadermatol.2022.6051","journal-title":"JAMA Dermatol"},{"key":"2571_CR18","doi-asserted-by":"publisher","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ et al (2021) Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomisation (Strobe-Mr): Explanation and Elaboration. Bmj 375:n2233. Epub 2021\/10\/28. https:\/\/doi.org\/10.1136\/bmj.n2233","DOI":"10.1136\/bmj.n2233"},{"issue":"6","key":"2571_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","volume":"53","author":"J Chen","year":"2021","unstructured":"Chen J, Spracklen CN, Marenne G, Varshney A, Corbin LJ, Luan J et al (2021) The Trans-Ancestral genomic architecture of glycemic traits. Nat Genet 53(6):840\u2013860 Epub 2021\/06\/02. https:\/\/doi.org\/10.1038\/s41588-021-00852-9","journal-title":"Nat Genet"},{"issue":"8","key":"2571_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00125-023-05925-4","volume":"66","author":"J Yarmolinsky","year":"2023","unstructured":"Yarmolinsky J, Bouras E, Constantinescu A, Burrows K, Bull CJ, Vincent EE et al (2023) Genetically proxied Glucose-Lowering drug target perturbation and risk of cancer: A Mendelian randomisation analysis. Diabetologia 66(8):1481\u20131500 Epub 2023\/05\/12. https:\/\/doi.org\/10.1007\/s00125-023-05925-4","journal-title":"Diabetologia"},{"issue":"5","key":"2571_CR21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","volume":"54","author":"A Mahajan","year":"2022","unstructured":"Mahajan A, Spracklen CN, Zhang W, Ng MCY, Petty LE, Kitajima H et al (2022) Multi-Ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet 54(5):560\u2013572 Epub 2022\/05\/14. https:\/\/doi.org\/10.1038\/s41588-022-01058-3","journal-title":"Nat Genet"},{"issue":"7708","key":"2571_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J et al (2018) Genomic atlas of the human plasma proteome. Nature 558(7708):73\u201379 Epub 2018\/06\/08. https:\/\/doi.org\/10.1038\/s41586-018-0175-2","journal-title":"Nature"},{"key":"2571_CR23","doi-asserted-by":"publisher","unstructured":"Zheng J, Xu M, Yang Q, Hu C, Walker V, Lu J et al (2023) Efficacy of Metformin targets on cardiometabolic health in the general population and Non-Diabetic individuals: A Mendelian randomization study. EBioMedicine 96(104803). https:\/\/doi.org\/10.1016\/j.ebiom.2023.104803. Epub 2023\/09\/22","DOI":"10.1016\/j.ebiom.2023.104803"},{"issue":"1","key":"2571_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s12967-023-04565-x","volume":"21","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Li M, Wang H, Yang F, Pang X, Du R et al (2023) Genetically proxied antidiabetic drugs targets and stroke risk. J Transl Med 21(1):681 Epub 2023\/10\/01. https:\/\/doi.org\/10.1186\/s12967-023-04565-x","journal-title":"J Transl Med"},{"issue":"1","key":"2571_CR25","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1038\/s41467-021-26280-1","volume":"12","author":"CS Storm","year":"2021","unstructured":"Storm CS, Kia DA, Almramhi MM, Bandres-Ciga S, Finan C, Hingorani AD et al (2021) Finding Genetically-Supported drug targets for parkinson\u2019s disease using Mendelian randomization of the druggable genome. Nat Commun 12(1):7342 Epub 2021\/12\/22. https:\/\/doi.org\/10.1038\/s41467-021-26280-1","journal-title":"Nat Commun"},{"issue":"3","key":"2571_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","volume":"75","author":"X Xiong","year":"2019","unstructured":"Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S et al (2019) Landscape of intercellular crosstalk in healthy and Nash liver revealed by Single-Cell secretome gene analysis. Mol Cell 75(3):644\u201360e5. https:\/\/doi.org\/10.1016\/j.molcel.2019.07.028. Epub 2019\/08\/10","journal-title":"Mol Cell"},{"issue":"1","key":"2571_CR27","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1038\/s41467-023-40156-6","volume":"14","author":"A Garrido-Trigo","year":"2023","unstructured":"Garrido-Trigo A, Corraliza AM, Veny M, Dotti I, Mel\u00f3n-Ardanaz E, Rill A et al (2023) Macrophage and neutrophil heterogeneity at Single-Cell Spatial resolution in human inflammatory bowel disease. Nat Commun 14(1):4506 Epub 2023\/07\/27. https:\/\/doi.org\/10.1038\/s41467-023-40156-6","journal-title":"Nat Commun"},{"key":"2571_CR28","doi-asserted-by":"publisher","first-page":"1247611","DOI":"10.3389\/fendo.2023.1247611","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Ji G, Li M (2023) Glucokinase regulatory protein: A balancing act between glucose and lipid metabolism in Nafld. Front Endocrinol (Lausanne) 14:1247611 Epub 2023\/09\/15. https:\/\/doi.org\/10.3389\/fendo.2023.1247611","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2571_CR29","doi-asserted-by":"publisher","unstructured":"Kupnicka P, Kr\u00f3l M, \u017bychowska J, \u0141agowski R, Prajwos E, Sur\u00f3wka A et al (2024) Glp-1 receptor agonists: A promising therapy for modern lifestyle diseases with unforeseen challenges. Pharmaceuticals (Basel) 17(11). https:\/\/doi.org\/10.3390\/ph17111470. Epub 2024\/11\/27","DOI":"10.3390\/ph17111470"},{"issue":"5","key":"2571_CR30","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00125-021-05390-x","volume":"64","author":"S Tornovsky-Babeay","year":"2021","unstructured":"Tornovsky-Babeay S, Weinberg-Corem N, Ben-Haroush Schyr R, Avrahami D, Lavi J, Feleke E et al (2021) Biphasic dynamics of beta cell mass in a mouse model of congenital hyperinsulinism: implications for type 2 diabetes. Diabetologia 64(5):1133\u20131143 Epub 2021\/02\/10. https:\/\/doi.org\/10.1007\/s00125-021-05390-x","journal-title":"Diabetologia"},{"issue":"5","key":"2571_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40265-020-01278-z","volume":"80","author":"KA Toulis","year":"2020","unstructured":"Toulis KA, Nirantharakumar K, Pourzitaki C, Barnett AH, Tahrani AA (2020) Glucokinase activators for type 2 diabetes: challenges and future developments. Drugs 80(5):467\u2013475 Epub 2020\/03\/13. https:\/\/doi.org\/10.1007\/s40265-020-01278-z","journal-title":"Drugs"},{"key":"2571_CR32","doi-asserted-by":"publisher","first-page":"109452","DOI":"10.1016\/j.jnutbio.2023.109452","volume":"122","author":"Y Gong","year":"2023","unstructured":"Gong Y, Lu Q, Xi L, Liu Y, Yang B, Su J et al (2023) F6p\/G6p-Mediated Chrebp activation promotes the insulin Resistance-Driven hepatic lipid deposition in zebrafish. J Nutr Biochem 122:109452 Epub 2023\/09\/26. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109452","journal-title":"J Nutr Biochem"},{"key":"2571_CR33","doi-asserted-by":"publisher","unstructured":"Remedi MS, Nichols CG (2023) Glucokinase Inhibition: A Novel Treatment for Diabetes? Diabetes 72(2):170-4. Epub 2023\/01\/21. https:\/\/doi.org\/10.2337\/db22-0731","DOI":"10.2337\/db22-0731"},{"issue":"3","key":"2571_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/gutjnl-2023-330784","volume":"73","author":"L Chen","year":"2024","unstructured":"Chen L, Qiu W, Sun X, Gao M, Zhao Y, Li M et al (2024) Novel insights into causal effects of serum lipids and Lipid-Modifying targets on cholelithiasis. Gut 73(3):521\u2013532 Epub 2023\/11\/10. https:\/\/doi.org\/10.1136\/gutjnl-2023-330784","journal-title":"Gut"},{"issue":"4","key":"2571_CR35","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/hep.32183","volume":"75","author":"L Chen","year":"2022","unstructured":"Chen L, Yang H, Li H, He C, Yang L, Lv G (2022) Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study. Hepatology 75(4):785\u2013796 Epub 2021\/10\/09. https:\/\/doi.org\/10.1002\/hep.32183","journal-title":"Hepatology"},{"issue":"1","key":"2571_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12944-022-01635-9","volume":"21","author":"M Zhang","year":"2022","unstructured":"Zhang M, Mao M, Zhang C, Hu F, Cui P, Li G et al (2022) Blood lipid metabolism and the risk of gallstone disease: A Multi-Center study and Meta-Analysis. Lipids Health Dis 21(1):26 Epub 2022\/03\/04. https:\/\/doi.org\/10.1186\/s12944-022-01635-9","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2571_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41598-023-50459-9","volume":"14","author":"M Xu","year":"2024","unstructured":"Xu M, Liu D, Tan Y, He J, Zhou B (2024) A Mendelian randomization study on the effects of plasma lipids on irritable bowel syndrome and functional dyspepsia. Sci Rep 14(1):78 Epub 2024\/01\/04. https:\/\/doi.org\/10.1038\/s41598-023-50459-9","journal-title":"Sci Rep"},{"issue":"5","key":"2571_CR38","doi-asserted-by":"publisher","first-page":"e14234","DOI":"10.1111\/nmo.14234","volume":"34","author":"S Fu","year":"2022","unstructured":"Fu S, Xu M, Zhou H, Wang Y, Tan Y, Liu D (2022) Metabolic syndrome is associated with higher rate of gastroesophageal reflux disease: A Meta-Analysis. Neurogastroenterol Motil 34(5):e14234 Epub 2021\/08\/12. https:\/\/doi.org\/10.1111\/nmo.14234","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"2571_CR39","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","volume":"77","author":"M Peiseler","year":"2022","unstructured":"Peiseler M, Schwabe R, Hampe J, Kubes P, Heikenw\u00e4lder M, Tacke F (2022) Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver Disease - Novel insights into cellular communication circuits. J Hepatol 77(4):1136\u20131160 Epub 2022\/06\/25. https:\/\/doi.org\/10.1016\/j.jhep.2022.06.012","journal-title":"J Hepatol"},{"issue":"10","key":"2571_CR40","doi-asserted-by":"publisher","first-page":"166480","DOI":"10.1016\/j.bbadis.2022.166480","volume":"1868","author":"B Yang","year":"2022","unstructured":"Yang B, Luo W, Wang M, Tang Y, Zhu W, Jin L et al (2022) Macrophage-Specific Myd88 deletion and Pharmacological Inhibition prevents liver damage in Non-Alcoholic fatty liver disease via reducing inflammatory response. Biochim Biophys Acta Mol Basis Dis 1868(10):166480 Epub 2022\/07\/11. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166480","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2571_CR41","doi-asserted-by":"publisher","first-page":"111688","DOI":"10.1016\/j.diabres.2024.111688","volume":"212","author":"MP Cooreman","year":"2024","unstructured":"Cooreman MP, Vonghia L, Francque SM (2024) Masld\/Mash and type 2 diabetes: two sides of the same coin?? From single Ppar to Pan-Ppar agonists. Diabetes Res Clin Pract 212:111688 Epub 2024\/05\/03. https:\/\/doi.org\/10.1016\/j.diabres.2024.111688","journal-title":"Diabetes Res Clin Pract"},{"key":"2571_CR42","doi-asserted-by":"publisher","first-page":"155264","DOI":"10.1016\/j.metabol.2022.155264","volume":"134","author":"M Yan","year":"2022","unstructured":"Yan M, Man S, Ma L, Gao W (2022) Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: an overview and current perspectives. Metabolism 134:155264 Epub 2022\/07\/11. https:\/\/doi.org\/10.1016\/j.metabol.2022.155264","journal-title":"Metabolism"},{"key":"2571_CR43","doi-asserted-by":"publisher","unstructured":"Caioni G, Viscido A, d\u2019Angelo M, Panella G, Castelli V, Merola C et al (2021) Inflammatory Bowel Disease: New Insights into the Interplay between Environmental Factors and Ppar\u03b3. Int J Mol Sci 22(3). Epub 2021\/01\/28. https:\/\/doi.org\/10.3390\/ijms22030985","DOI":"10.3390\/ijms22030985"},{"key":"2571_CR44","doi-asserted-by":"publisher","first-page":"114956","DOI":"10.1016\/j.intimp.2025.114956","volume":"159","author":"Y Xia","year":"2025","unstructured":"Xia Y, Zhou X, Cai P, Yan R, Ocansey DKW, Mao F (2025) Flos lonicerae polysaccharide alleviates inflammatory bowel disease by improving intestinal microbiota and inhibiting oxidative stress and the Nf-\u039ab pathway. Int Immunopharmacol 159:114956 Epub 2025\/05\/27. https:\/\/doi.org\/10.1016\/j.intimp.2025.114956","journal-title":"Int Immunopharmacol"},{"key":"2571_CR45","doi-asserted-by":"publisher","first-page":"155329","DOI":"10.1016\/j.metabol.2022.155329","volume":"137","author":"SC Larsson","year":"2022","unstructured":"Larsson SC, Micha\u00eblsson K, Mola-Caminal M, H\u00f6ijer J, Mantzoros CS (2022) Genome-Wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly Nash. Metabolism 137:155329 Epub 2022\/10\/09. https:\/\/doi.org\/10.1016\/j.metabol.2022.155329","journal-title":"Metabolism"},{"issue":"1","key":"2571_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cmet.2023.11.010","volume":"36","author":"C Singh","year":"2024","unstructured":"Singh C, Jin B, Shrestha N, Markhard AL, Panda A, Calvo SE et al (2024) Chrebp is activated by reductive stress and mediates Gckr-Associated metabolic traits. Cell Metab 36(1):144\u2013158.e7. Epub 2023\/12\/16. https:\/\/doi.org\/10.1016\/j.cmet.2023.11.010","journal-title":"Cell Metab"},{"issue":"7814","key":"2571_CR47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-020-2337-2","volume":"583","author":"RP Goodman","year":"2020","unstructured":"Goodman RP, Markhard AL, Shah H, Sharma R, Skinner OS, Clish CB et al (2020) Hepatic Nadh reductive stress underlies common variation in metabolic traits. Nature 583(7814):122\u2013126 Epub 2020\/05\/29. https:\/\/doi.org\/10.1038\/s41586-020-2337-2","journal-title":"Nature"},{"key":"2571_CR48","doi-asserted-by":"publisher","first-page":"1394030","DOI":"10.3389\/fphys.2024.1394030","volume":"15","author":"A \u0141ukawska","year":"2024","unstructured":"\u0141ukawska A, Mulak A (2024) A correlation of serum fibroblast growth factor 21 level with inflammatory markers and indicators of nutritional status in patients with inflammatory bowel disease. Front Physiol 15:1394030 Epub 2024\/07\/10. https:\/\/doi.org\/10.3389\/fphys.2024.1394030","journal-title":"Front Physiol"},{"key":"2571_CR49","doi-asserted-by":"publisher","unstructured":"Liu L, Li F, Shao T, Zhang L, Lee J, Dryden G et al (2023) Fgf21 depletion attenuates colitis through intestinal epithelial Il-22-Stat3 activation in mice. Nutrients 15(9). https:\/\/doi.org\/10.3390\/nu15092086. Epub 2023\/07\/11","DOI":"10.3390\/nu15092086"},{"key":"2571_CR50","doi-asserted-by":"publisher","first-page":"155616","DOI":"10.1016\/j.metabol.2023.155616","volume":"145","author":"A Giontella","year":"2023","unstructured":"Giontella A, Zagkos L, Geybels M, Larsson SC, Tzoulaki I, Mantzoros CS et al (2023) Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, Proteome-Wide and Metabolome-Wide association study. Metabolism 145:155616 Epub 2023\/06\/12. https:\/\/doi.org\/10.1016\/j.metabol.2023.155616","journal-title":"Metabolism"},{"key":"2571_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333213","author":"F Link","year":"2024","unstructured":"Link F, Li Y, Zhao J, Munker S, Fan W, Nwosu ZC et al (2024) Ecm1 attenuates hepatic fibrosis by interfering with mediators of latent Tgf-\u03921 activation. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2024-333213. Epub 2024\/10\/25","journal-title":"Gut"},{"issue":"2","key":"2571_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41423-022-00966-y","volume":"20","author":"Q Song","year":"2023","unstructured":"Song Q, Datta S, Liang X, Xu X, Pavicic P, Zhang X et al (2023) Type I interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization. Cell Mol Immunol 20(2):143\u2013157 Epub 2023\/01\/04. https:\/\/doi.org\/10.1038\/s41423-022-00966-y","journal-title":"Cell Mol Immunol"},{"key":"2571_CR53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biopha.2017.12.027","volume":"98","author":"M Najar","year":"2018","unstructured":"Najar M, Fayyad-Kazan H, Faour WH, El Taghdouini A, Raicevic G, van Grunsven LA et al (2018) Immuno-Biological comparison of hepatic stellate cells in a reverted and activated state. Biomed Pharmacother 98:52\u201362 Epub 2017\/12\/16. https:\/\/doi.org\/10.1016\/j.biopha.2017.12.027","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2571_CR54","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1093\/ibd\/izae098","volume":"30","author":"G Kokkotis","year":"2024","unstructured":"Kokkotis G, Filidou E, Tarapatzi G, Spathakis M, Kandilogiannakis L, Dovrolis N et al (2024) Oncostatin M induces a Pro-Inflammatory phenotype in intestinal subepithelial myofibroblasts. Inflamm Bowel Dis 30(11):2162\u20132173 Epub 2024\/05\/08. https:\/\/doi.org\/10.1093\/ibd\/izae098","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"2571_CR55","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1136\/gutjnl-2022-328421","volume":"72","author":"H Leibovitzh","year":"2023","unstructured":"Leibovitzh H, Lee SH, Raygoza Garay JA, Espin-Garcia O, Xue M, Neustaeter A et al (2023) Immune response and barrier Dysfunction-Related proteomic signatures in preclinical phase of crohn\u2019s disease highlight earliest events of pathogenesis. Gut 72(8):1462\u20131471 Epub 2023\/02\/15. https:\/\/doi.org\/10.1136\/gutjnl-2022-328421","journal-title":"Gut"},{"issue":"1","key":"2571_CR56","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1038\/s41598-018-24446-4","volume":"8","author":"K Vi\u0161kovi\u0107","year":"2018","unstructured":"Vi\u0161kovi\u0107 K, \u017didovec Lepej S, Gorenec A, Grgi\u0107 I, Lukas D, Zekan \u0160 et al (2018) Cardiovascular markers of inflammation and serum lipid levels in Hiv-Infected patients with undetectable viremia. Sci Rep 8(1):6113 Epub 2018\/04\/19. https:\/\/doi.org\/10.1038\/s41598-018-24446-4","journal-title":"Sci Rep"},{"issue":"12","key":"2571_CR57","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.biopsych.2023.12.024","volume":"95","author":"Z Li","year":"2024","unstructured":"Li Z, Ma Q, Deng Y, Rolls ET, Shen C, Li Y et al (2024) Irritable bowel syndrome is associated with brain health by neuroimaging, behavioral, biochemical, and genetic analyses. Biol Psychiatry 95(12):1122\u20131132 Epub 2024\/01\/11. https:\/\/doi.org\/10.1016\/j.biopsych.2023.12.024","journal-title":"Biol Psychiatry"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-025-02571-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:01:42Z","timestamp":1766509302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-025-02571-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2571"],"URL":"https:\/\/doi.org\/10.1007\/s00592-025-02571-7","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}